Corrigendum to “Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer” [Pharmacology & Therapeutics 239 (2022) 108296]
Saved in:
Published in | Pharmacology & therapeutics (Oxford) Vol. 243; p. 108336 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Inc
01.03.2023
|
Online Access | Get full text |
Cover
Loading…
ArticleNumber | 108336 |
---|---|
Author | Sun, Wenshe Ming, Tao Huang, Binghuan Huang, Haiming Liu, Xinlin Deng, Junwen Chen, Wujun Liang, Bing Wen, Jialian Yuan, Yang Wang, Yanhong Xing, Dongming |
Author_xml | – sequence: 1 givenname: Xinlin surname: Liu fullname: Liu, Xinlin organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China – sequence: 2 givenname: Junwen surname: Deng fullname: Deng, Junwen organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China – sequence: 3 givenname: Yang surname: Yuan fullname: Yuan, Yang organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China – sequence: 4 givenname: Wujun surname: Chen fullname: Chen, Wujun organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China – sequence: 5 givenname: Wenshe surname: Sun fullname: Sun, Wenshe organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China – sequence: 6 givenname: Yanhong surname: Wang fullname: Wang, Yanhong organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China – sequence: 7 givenname: Haiming surname: Huang fullname: Huang, Haiming organization: Shanghai Asia United Antibody Medical Co., Ltd, Shanghai 201203, China – sequence: 8 givenname: Bing surname: Liang fullname: Liang, Bing organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China – sequence: 9 givenname: Tao surname: Ming fullname: Ming, Tao organization: Aerospace Information Research Institute, Chinese Academy of Sciences, Beijing 100094, China – sequence: 10 givenname: Jialian surname: Wen fullname: Wen, Jialian organization: School of Social Science, The University of Manchester, Manchester, UK – sequence: 11 givenname: Binghuan surname: Huang fullname: Huang, Binghuan organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China – sequence: 12 givenname: Dongming surname: Xing fullname: Xing, Dongming email: xdm_tsinghua@163.com organization: Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36804040$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUctuEzEUtVARTQu_gLxCZTHBr8yDXYl4SRWwCBISQpYfd1JHM-PB9kTKrh9Sfq5fgqcpsEReXOnqPO7xOUMngx8AIUzJkhJavtotx2sV-nQNQS0ZYSyva87LR2hB66opMubbCVrkwYuKrepTdBbjjhAiBGFP0CkvayLyW6DbtQ_BbWGwU4-Tx3c3t5d2rwYDEbsBb4IfWZFU2EICi-8Nx8Nr_MnvocMq81LEarDYj6MPaRpccpmp4eDzUgdQMWEzy4W7m1_4-5f5bGV857cH_AJv7vVgSs5EzHiDL-YwL3POmjXlj6focau6CM8e5jn6-u7tZv2huPr8_uP68qowjIqyUIKR1oCqdMlLSistaENrIFZQ1jartmk1b6qWCKstrBRjWjOhGqAGBAGz4ufo4qg7Bv9zgphk76KBrlMD-ClKVlV1U3FSVxlaH6Em-BgDtHIMrlfhICmRczdyJ_91I-c48thNpj5_cJl0D_Yv8U8ZGfDmCICcde8gyGgc5L-zLoBJ0nr3f5ffMsepAA |
ContentType | Journal Article |
Copyright | 2022 The Author(s) |
Copyright_xml | – notice: 2022 The Author(s) |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.pharmthera.2022.108336 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1879-016X |
EndPage | 108336 |
ExternalDocumentID | 10_1016_j_pharmthera_2022_108336 36804040 S0163725822002303 |
Genre | Published Erratum Correction/Retraction |
GroupedDBID | --- --K --M .GJ .~1 0R~ 123 1B1 1RT 1~. 1~5 29O 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXUO ABFNM ABMAC ABXDB ABYKQ ABZDS ACDAQ ACGFO ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMT HVGLF HZ~ IHE J1W K-O KOM L7B M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SPT SSP SSZ T5K TEORI WUQ Y6R ZGI ZXP ~G- AAXKI AFJKZ AKRWK NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c2146-a420fcea7b636117b41918e0d412f95f9fb397f04dbde5a22bb24a9e1ce40ec53 |
IEDL.DBID | AIKHN |
ISSN | 0163-7258 |
IngestDate | Sat Oct 05 05:10:29 EDT 2024 Thu Sep 26 18:20:53 EDT 2024 Sat Sep 28 08:19:01 EDT 2024 Fri Feb 23 02:37:48 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2146-a420fcea7b636117b41918e0d412f95f9fb397f04dbde5a22bb24a9e1ce40ec53 |
Notes | erratum SourceType-Other Sources-1 content type line 63 ObjectType-Correction/Retraction-1 |
OpenAccessLink | https://doi.org/10.1016/j.pharmthera.2022.108336 |
PMID | 36804040 |
PQID | 2778973087 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_2778973087 crossref_primary_10_1016_j_pharmthera_2022_108336 pubmed_primary_36804040 elsevier_sciencedirect_doi_10_1016_j_pharmthera_2022_108336 |
PublicationCentury | 2000 |
PublicationDate | March 2023 2023-Mar 2023-03-00 20230301 |
PublicationDateYYYYMMDD | 2023-03-01 |
PublicationDate_xml | – month: 03 year: 2023 text: March 2023 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Pharmacology & therapeutics (Oxford) |
PublicationTitleAlternate | Pharmacol Ther |
PublicationYear | 2023 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | 36208791 - Pharmacol Ther. 2022 Nov;239:108296 |
References_xml | |
SSID | ssj0004402 |
Score | 2.4563346 |
SecondaryResourceType | publication_corrigendum |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 108336 |
Title | Corrigendum to “Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer” [Pharmacology & Therapeutics 239 (2022) 108296] |
URI | https://dx.doi.org/10.1016/j.pharmthera.2022.108336 https://www.ncbi.nlm.nih.gov/pubmed/36804040 https://search.proquest.com/docview/2778973087 |
Volume | 243 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1di9QwFA27sy--iN-OrssVZFHYOk2aNK0-DYPLqDgsOAsLIiFfhRFtS2dmYV5kf8j65_aXmDSts4KC4Gtpmkvu7b0n7Tk3CD3DEmeK-S_3KjURxUpHkhMTGZY4LJdQbaVXI3-YpdNT-u6Mne2gSa-F8bTKLveHnN5m6-7KqFvNUb1YjD46sJJwwlyFa4F0sov2XDmidID2xm_fT2dbeSRtqYf-_sgP6Ag9geZV-w7RrdbJbRYJ8Zy7pO3X_Mcq9TcU2laj41voZgcjYRwsvY12bHkHHZ6EPtSbI5hvZVXLIziEk22H6s1ddDmpmsa34TTrb7Cq4Orichy4AEtYlDBvqppEgSNuDQSJ1uYVzKpz-xWkF2MtQZYGqtqj93XZdmUF1YphQHma-wq0f1xzdfEDPl2f3Nly3TYgSQ7P_ZK8cKuVkTz9fA-dHr-ZT6ZRd0xDpP2p4JGkJC6cT7lKkxRjrqjbA2Y2NhSTImdFXigHeoqYGmUsk4QoRajMLdaWxlaz5D4alFVpHyIwWmVuv2m15BnVaSqLrIiZtdRFEmcaDxHu3SLq0I1D9DS1L2LrSuHtFsGVQ_S695_4LbKEKxr_MPpp73LhXjz_N0WWtlovBeE8y7lvqDhED0Is_LIpSTOXHGn86L_mfoxu-MPtA-NtHw1Wzdo-cRBopQ7Q7svv-KAL9J_PXQj_ |
link.rule.ids | 315,786,790,4521,24144,27955,27956,45618,45712 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1da9RAFB1qfdAX8dttq15BikLjJpNJJtGnslhWbZeCWyiIDPMVWNEkZHeFfSn9IfXP9Zc4N5O4FRQEX8Mkc5l7c--Z5NwzhDyPZJSpBL_cq9QELFI6kJyawCSxw3Ix01ZiN_LRJB2fsPenyekGGfW9MEir7HK_z-lttu6uDLvVHNaz2fCjAysxp4mrcC2Qjq-R64gGkNf16mzN82CsJR7i6ACHd3QeT_KqUR-67XRyW0VKkXEXt2rNf6xRf8OgbS06uE1udSAS9r2dd8iGLe-S3WOvQr3ag-m6qWq-B7twvNanXt0jF6OqaVCE0yy_waKCy_OLfc8EmMOshGlT1TTwDHFrwDdorV7DpPpuv4LEVqw5yNJAVSN2X5atJiuothUGFJLcF6Dxcc3l-Q_4dHVyZ8tV24DGObzAJXnpViujefr5Pjk5eDsdjYPukIZA45nggWQ0LJxHuUrjNIq4Ym4HmNnQsIgWeVLkhXKQpwiZUcYmklKlKJO5jbRlodVJ_IBsllVpHxEwWmVut2m15BnTaSqLrAgTa5mLI57oaECi3i2i9locoiepfRFrVwq0W3hXDsib3n_it7gSrmT8w93PepcL99rhvxRZ2mo5F5TzLOcopzggD30s_LIpTjOXGlm49V9zPyU3xtOjQ3H4bvJhm9zEY-49922HbC6apX3swNBCPWmD_SczMwnU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Corrigendum+to+%E2%80%9CAdvances+in+Trop2-targeted+therapy%3A+Novel+agents+and+opportunities+beyond+breast+cancer%E2%80%9D+%5BPharmacology+%26+Therapeutics+239+%282022%29+108296%5D&rft.jtitle=Pharmacology+%26+therapeutics+%28Oxford%29&rft.au=Liu%2C+Xinlin&rft.au=Deng%2C+Junwen&rft.au=Yuan%2C+Yang&rft.au=Chen%2C+Wujun&rft.date=2023-03-01&rft.pub=Elsevier+Inc&rft.issn=0163-7258&rft.eissn=1879-016X&rft.volume=243&rft_id=info:doi/10.1016%2Fj.pharmthera.2022.108336&rft.externalDocID=S0163725822002303 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0163-7258&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0163-7258&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0163-7258&client=summon |